A 44-year-old white man was diagnosed with chronic hepatitis B in 1999 by his primary-care physician. His laboratory results were as follows: aspartate aminotransferase (AST) 144 IU/L, alanine aminotransferase (ALT) 82 IU/L, hepatitis B surface antigen (HBsAg) positive, hepatitis B e antigen (HBeAg)
The threat of hepatitis B virus recurrence: A sword of damocles to the liver transplant recipient
β Scribed by Teresa Wright
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 491 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
However, the authors failed to highlight other important results in their pilot study, that should be incorporated in the design of any future trial testing the validity of these preliminary findings. As noted by HEPATOLOGY Elsewhere 219 this heroic intervention cost-effective? In the end, in which if any patients with HCC is that level of success likely to be achieved?
π SIMILAR VOLUMES
The clinical significance of HGV infection is uncertain. ## Although hepatitis G virus infection (HGV) is usually Hepatitis G viremia has been documented in patients with asymptomatic, it has been associated with mild hepatic injury. acute hepatitis 1,6,7 and can persist for years, 1,5-7 althoug
Although rare in the pediatric population, the natural history of hepatitis C virus (HCV) recurrence in pediatric patients undergoing orthotopic liver transplantation (OLT) for end-stage liver disease secondary to HCV has not been well described. We performed an analysis of all 67 pediatric patients
The scarcity of liver donors requires consideration of grafts from sources not previously used. Allografts from hepatitis B surface antigen (HBsAg)-carriers without a significant liver disease have been proposed for liver transplant recipients with hepatitis B virus (HBV)-related cirrhosis and hepat